| 51. | | Recruiting | Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 52. | | Recruiting | Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
Conditions: recurrent endometrial cancer; endometrial papillary carcinoma |
| 53. | | Recruiting | Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
Conditions: recurrent metastatic squamous neck cancer with occult primary; metastatic squamous neck cancer with occult primary squamous cell carcinoma; ... |
| 54. | | Recruiting | Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix
Conditions: recurrent cervical cancer; stage IVB cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma |
| 55. | | Recruiting | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
Conditions: stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ... |
| 56. | | Recruiting | Study of Cetuximab in Combination with Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung |
| 57. | | Recruiting | Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
| 58. | | Recruiting | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Stage IIIb non-small cell lung cancer; Stage IV non-small cell lung cancer |
| 59. | | Completed | Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene into Peripheral Blood Progenitor Cells Followed by Intensification Therapy with Seque...
Conditions: Breast
Neoplasms; Neoplasm Metastasis |
| 60. | | Recruiting | A Phase I Study of the Combination of Continuous Daily CAI and Intermittent Paclitaxel in Adult Patients with Refractory Cancers or Lymphoma
Conditions: Lymphoma; Neoplasm; Neoplasm Metastasis |
| 61. | | Recruiting | Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 62. | | Recruiting | R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy
Conditions: stage IV breast cancer; recurrent breast cancer |
| 63. | | Recruiting | Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma
Condition: Colorectal Adenocarcinoma |
| 64. | | Recruiting | Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 65. | | Recruiting | Safety and Efficacy of S-8184 in Second Line Treatment of Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium
Condition: Urologic Neoplasms |
| 66. | | Recruiting | Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
Conditions: stage I breast cancer; stage II breast cancer |
| 67. | | Recruiting | Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer |
| 68. | | Recruiting | Combination Chemotherapy in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer |
| 69. | | Recruiting | Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
Conditions: stage III bladder cancer; recurrent bladder cancer; stage IV bladder cancer; squamous cell carcinoma of the bladder; adenocarcinoma of the bladder; ... |
| 70. | | Recruiting | Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer
Conditions: stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 71. | | Recruiting | Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
Conditions: stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer; oral complications of cancer and cancer therapy; ... |
| 72. | | Recruiting | Combination Chemotherapy Combined with Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus
Conditions: stage II esophageal cancer; stage III esophageal cancer |
| 73. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ... |
| 74. | | Recruiting | Combination Chemotherapy in Treating Women With Stage III Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: stage III ovarian epithelial cancer; peritoneal cavity cancer; fallopian tube cancer |
| 75. | | Recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
Conditions: recurrent testicular cancer; recurrent ovarian germ cell tumor; extragonadal germ cell tumor |
| 76. | | Recruiting | Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer
Condition: Ovarian Cancer |
| 77. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas |
| 78. | | Recruiting | Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ... |
| 79. | | Recruiting | A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin with G-CSF for Patients with Newly Diagnosed Advanced Stage Ovarian Cancer
Condition: Ovarian Neoplasm |
| 80. | | Recruiting | A Phase 3 Randomized Study of Lonafarnib in Combination With Paclitaxel and Carboplatin vs. Placebo in Combination with Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm |
| 81. | | Completed | Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients with Refractory Malignancy
Condition: Neoplasms |
| 82. | | Recruiting | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Conditions: stage III squamous cell carcinoma of the
oropharynx; stage IV squamous cell carcinoma of the oropharynx; ... |
| 83. | | Recruiting | Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Conditions: stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ... |
| 84. | | Recruiting | Chemotherapy Plus Surgery in Treating Women With Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer |
| 85. | | Recruiting | Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: adenosquamous cell lung cancer; bronchoalveolar cell lung cancer; large cell lung cancer; recurrent non-small cell lung cancer; ... |
| 86. | | Recruiting | Combination Chemotherapy, Gefitinib, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Conditions: squamous cell lung cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 87. | | Recruiting | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
| 88. | | Recruiting | Combination Chemotherapy, Monoclonal Antibody Therapy, and Surgery in Treating Women With Stage II, Stage III, or Stage IV Breast Cancer
Conditions: stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer |
| 89. | | Recruiting | Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ovarian undifferentiated
adenocarcinoma; ovarian serous cystadenocarcinoma; ... |
| 90. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; fallopian tube cancer; ... |
| 91. | | Recruiting | Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
Condition: Prostate Cancer |
| 92. | | Recruiting | A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma |
| 93. | | Recruiting | Trastuzumab Plus Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urinary Tract
Conditions: stage III bladder cancer; recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ... |
| 94. | | Recruiting | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer |
| 95. | | Recruiting | Combination Chemotherapy in Treating Men With Germ Cell Cancer
Conditions: stage III testicular cancer; testicular
seminoma; testicular embryonal carcinoma; testicular choriocarcinoma; testicular
teratoma; ... |
| 96. | | Recruiting | Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients with Stage I or Stage II Endometrial Cancer
Conditions: stage I endometrial cancer; stage II endometrial cancer; endometrial
adenocarcinoma; endometrial adenosquamous cell carcinoma; ... |
| 97. | | Recruiting | Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
Conditions: stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; stage I esophageal cancer; ... |
| 98. | | Recruiting | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
Conditions: stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage I esophageal cancer; stage II esophageal cancer; ... |
| 99. | | Recruiting | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Conditions: stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer |
| 100. | | Recruiting | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
